Monash Ivf Group Ltd

AU:MVF Australia Diagnostics & Research
Market Cap
$154.40 Million
AU$249.37 Million AUD
Market Cap Rank
#17570 Global
#260 in Australia
Share Price
AU$0.64
Change (1 day)
+1.59%
52-Week Range
AU$0.55 - AU$1.14
All Time High
AU$1.65
Categories
Companies in Australia Diagnostics & Research
About

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Au… Read more

Monash Ivf Group Ltd - Asset Resilience Ratio

Latest as of June 2025: 1.91%

Monash Ivf Group Ltd (MVF) has an Asset Resilience Ratio of 1.91% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$9.43 Million
Cash + Short-term Investments
Total Assets
AU$492.61 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Monash Ivf Group Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Monash Ivf Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$9.43 Million 1.91%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$9.43 Million 1.91%

Asset Resilience Insights

  • Limited Liquidity: Monash Ivf Group Ltd maintains only 1.91% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Monash Ivf Group Ltd Industry Peers by Asset Resilience Ratio

Compare Monash Ivf Group Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF 		Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710 		Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860 		Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980 		Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820 		Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310 		Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510 		Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710 		Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Monash Ivf Group Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Monash Ivf Group Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 0.11% AU$543.00K AU$492.61 Million -0.30pp
2024-06-30 0.41% AU$2.06 Million AU$508.47 Million -0.01pp
2023-06-30 0.41% AU$1.75 Million AU$421.89 Million +0.16pp
2022-06-30 0.25% AU$967.00K AU$387.10 Million -0.24pp
2021-06-30 0.49% AU$1.75 Million AU$356.17 Million -0.07pp
2020-06-30 0.57% AU$2.00 Million AU$354.22 Million +0.37pp
2019-06-30 0.19% AU$565.00K AU$290.04 Million +0.00pp
2018-06-30 0.19% AU$565.00K AU$290.61 Million 0.00pp
2017-06-30 0.20% AU$565.00K AU$287.25 Million --
pp = percentage points